生物技术新型药物输送系统用于与年龄相关的黄斑变性
S Amatha1, R Das2, M K Gautam3
1Department of Pharmaceutical Regulatory Affairs and Management, Manipal College of Pharmaceutical Sciences MAHE-Manipal, Karnataka, India.
Archivos de la Sociedad Espanola de Oftalmologia
|July 23, 2025
概括
新型生物技术眼部药物输送系统,包括基因和基于细胞的疗法,显示出治疗与年龄相关的黄斑变性 (AMD) 的前景. 了解挑战和监管方面对于患者的生活质量至关重要.
科学领域:
- 生物技术是生物技术.
- 眼科医生 眼科 眼科
- 再生医学是一种再生医学.
背景情况:
- 与年龄相关的黄斑变性 (AMD) 是导致视力丧失的主要原因.
- 目前对AMD的治疗有局限性.
- 生物技术的进步为治疗提供了新的途径.
研究的目的:
- 审查用于AMD的新型生物技术眼部药物输送系统.
- 探索基因和基于细胞的AMD治疗方法.
- 讨论市场翻译的挑战和监管考虑.
主要方法:
- 对基因疗法,基于细胞的系统和用于眼部输送的向载体的文献综述.
- 对安全性,生物相容性和监管方面的分析.
- 审查正在进行的AMD治疗临床试验.
主要成果:
- 基因疗法和基于细胞的系统对AMD治疗具有前景.
- 在开发和市场翻译方面存在重大挑战.
- 合作的专家团队和监管理解至关重要.
结论:
- 生物技术眼部输送代表了向个人化AMD药物的转变.
- 这些新疗法有可能改善患者的生活质量.
- 进一步的研究和临床试验对于安全性和有效性至关重要.
关键词:
生物技术新药的管理.与年龄相关的黄斑变性.与年龄相关的黄斑退化.基因治疗是一种基因疗法.个性化的医药 (Medicina personalizada) 是一种个性化的药物.新型生物技术药物输送方式个性化医疗是个性化的医疗.基因疗法是一种基因疗法.更多相关视频
07:49Slow-release Drug Delivery through Elvax 40W to the Rat Retina: Implications for the Treatment of Chronic Conditions
Published on: September 17, 2014
11.7K
06:48Limbal Approach-Subretinal Injection of Viral Vectors for Gene Therapy in Mice Retinal Pigment Epithelium
Published on: August 7, 2015
21.5K
相关概念视频
Drug Delivery: Miscellaneous Routes
468
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
468
iPS Cell Differentiation
2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
